Dr. Nikhil Paleka, Director of the Stony Brook Center of Excellence for Alzheimer's Disease, joined Health and Well Being with Steve Scott to discuss the newly approved Alzheimer's drug
Health and Well Being
2,112 clip(s)
Alzheimer's drug has slowed progression of symptoms by 35% in patients
FDA gives final approval to Alzheimer's drug
The benefits of an awake kidney surgery